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Purpose: A recurrent 17 bp duplication (c.657ins17bp) of a segment of the paired-like homeodomain transcription factor
3 (PITX3) gene on human chromosome 10 has been reported in seven families with autosomal dominant posterior polar
cataracts with or without anterior segment mesenchymal dysgenesis (ASMD). ASMD can include Peters anomaly with
corneal clouding, iridolenticular corneal adhesions, displaced Schwalbe’s line, and cataract as described previously in a
large Australian family. This study reports the examination of PITX3 in this Australian family.
Methods: Clinical examinations of the proband and her relatives were performed as part of routine follow up. A
polymerase chain reaction (PCR) based test for the duplication in PITX3 was developed, and DNA from 21 members of
the proband’s family was tested.
Results: All clinically affected members of the family had the same 17 bp duplication of PITX3. There was no difference
in the size of the duplication between the severely affected individuals and the more mildly affected individuals. Prenatal
diagnosis was performed for two offspring of one affected person. In the first pregnancy, the fetus was shown to carry the
duplication while in the second pregnancy, the fetus was shown to be homozygous for the normal allele.
Conclusions: The results show that in some individuals within one family, duplication of this segment of PITX3 can result
in severe symptoms leading to functional blindness while in other individuals in the same family or in other families, the
same duplication leads to treatable cataract with minimal visual impairment.
The term, Peters anomaly, describes an abnormality of
the embryonic development of the anterior segment of the eye
[1]. Affected individuals may have corneal clouding and
displaced Schwalbe’s line; adhesions between the cornea, iris,
and lens; and early development of cataracts. This complex of
ocular signs has been called anterior segment mesenchymal
dysgenesis (ASMD) [2]. We have described a four-generation
family with variable expression of ASMD, from one
individual with clouding of both corneas resulting in
blindness, to several family members with bilateral early onset
cataracts only. In total, seven individuals had some signs of
ASMD while eight had cataract as the only manifestation
[3]. Cataracts were detected as early as one year of age and
were extracted between the ages of 8 and 38 years. The
condition in this family was considered to be inherited in an
autosomal dominant fashion. We noted that the lack of male
to male transmission was also consistent with X-linked
dominant inheritance, although there were very few males at
risk [3].
Peters anomaly has been associated with abnormalities of
several genes that have a role in the development of the
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anterior segment of the eye (Table 1). We ruled out linkage
with a segment of the paired box 6 (PAX6) gene in our family
[3] and could not find linkage with chromosome 4 markers
(unpublished). A 17 bp duplication of a segment of the paired-
like homeodomain transcription factor 3 (PITX3) gene was
initially discovered in a large family with ASMD [4]. More
recently, the same duplication has been reported in six
families with posterior polar cataract [5-7]. A single base
deletion in the same gene has also been seen in a posterior
polar cataract family [5]. Very few affected individuals in
these families (5/106) had ASMD [5-8], indicating that
cataract is the major manifestation of the mutations in this
gene [5].
Causes of phenotypic variability in the families with this
duplication have not yet been elucidated. One possibility is
that more severely affected individuals have an amplification
of the insertion, since duplication of the segment could
predispose them to unequal crossing-over events at meiosis or
to replication slippage. Consistent with this hypothesis, there
has been increasing severity of the condition over several
generations in some branches of the family we have studied
[3], suggesting the phenomenon of anticipation (see [9] for a
review). We now provide a clinical update and report analysis
of PITX3 in this Australian ASMD family.
Molecular Vision 2008; 14:2010-2015 <http://www.molvis.org/molvis/v14/a237>
Received 02 October 2008 | Accepted 28 October 2008 | Published 5 November 2008
© 2008 Molecular Vision
2010
METHODS
The study was approved by the Ethics Committee of the Royal
Children’s Hospital in Brisbane, Australia. Informed consent
was obtained from all adults and from the appropriate adult
guardian for the children. Figure 1 shows the pedigree.
Individual identification numbers are the same as in the
previous paper [3] with the addition of the spouse and children
of III-5 (III-15, IV-9, and IV-10). Results of detailed clinical
investigations covering several years have been described
[3]. At a recent investigation, the proband (IV-2) had hand
movement vision in her right eye where severe corneal
clouding has persisted from birth (Figure 2A). She had
divergent strabismus of this eye, which was corrected with
surgery at the age of four years for cosmetic reasons. The left
eye had opacity of the peripheral cornea, displaced
Schwalbe’s line, and iris adhesions (Figure 2B). Vision in the
left eye was 6/18 at the age of 12 years and 6 months and 6/24
at the age of 14 years due to progressive posterior subcapsular
cataract. At 12 years and 6 months, intraocular pressures were
33 mmHg in the right eye and 12 mmHg in the left (normal
IOP ranges: 10–20 mmHg). She is currently wearing a colored
contact lens in the right eye to mask the corneal opacity
(Figure 2C). One affected individual, IV-9, was born since the
last report. She was shown at the age of six months to have a
small lamellar opacity in the left lens cortex, which did not
progress over the next nine months. The right lens remained
clear at 15 months of age. There were no other abnormalities
of the anterior segment in this child.
DNA was extracted from venous blood samples as
reported previously [3]. PITX3 was screened by amplifying a
214 bp fragment of exon 4, the site of the 17 bp insertion in
other families (Figure 3). The primers used were GCT CGC
CGC CAA GAC CTT TC (forward) and CGA GGC ATA
AGG GCA GGA CA (reverse). Reactions were performed in
a final volume of 10 μl that contained 1.75 pmol of each
primer, 1.5 mM MgSO4, 0.2 mM dNTPs, 3X PCRx Enhancer
Figure 1. Pedigree of the anterior segment mesenchymal dysgenesis
family. Clinical details are available in the previous paper [3].
Clinical details for IV-9 who has been born since that publication are
presented in Methods. Grey symbols indicate individuals with
cataract only, and black symbols indicate family members with
cataract and additional anterior segment eye abnormalities. The
proband, IV-2, is indicated with an arrow.
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TABLE 1. GENES ASSOCIATED WITH PETERS ANOMALY AND ANTERIOR SEGMENT MESENCHYMAL DYSGENESIS.
Gene name Protein function Chromosome
     location
Major phenotype
associated with mutations
Inheritance
  of ASMD
Reference
for ASMD
FOXE3 Transcription factor with fork-
head DNA binding domain
1p32 ASMD (aphakia when
homozygous or compound
heterozygous)
Dominant [12]
CYP1B1 Monomeric mixed function
mono-oxygenase, dioxin
responsive
2p22-p21 Congenital glaucoma                  Recessive [13]
PITX2/RIEG1 Transcription factor with
bicoid paired DNA binding
domain
4q25 Axenfeld-Rieger syndrome
(ocular, dental and
umbilical abnormalities)
Dominant [14]
FOXC1 Transcription factor with
forkhead DNA binding domain
6p25 Spectrum of ocular and
extraocular phenotypes
including congenital
glaucoma, Rieger anomaly,
Axenfeld anomaly, cardiac
abnormalities
Dominant [15]
PITX3 Transcription factor with
bicoid paired DNA binding
domain
10q25 Posterior polar cataract               Dominant [4]
PAX6 Transcription factor with
paired type DNA binding
domain
11p13 Aniridia Dominant [16]
B3GALTL Glycosyl transferase 13q12.3 Peters Plus syndrome
(ocular, facial,
developmental and stature
abnormalities)
Recessive [17]
Figure 2. Proband, IV-2, at the age of 12 years and 6 months. A shows
the severely affected right eye with peripheral sclerocornea. B shows
the mildly affected left eye, with peripheral corneal  stromal opacity
and displaced Schwalbe's line. C shows the proband's eyes without
(upper) and with (lower) a colored contact lens in the right eye to
mask the corneal opacity.
Solution (PCR, polymerase chain reaction; Invitrogen, Mt.
Waverley, Victoria, Australia), 0.4 units Platinum Taq
Polymerase (Invitrogen), 1X PCR amplification buffer
(Invitrogen), and 100 ng genomic DNA. The amplification
procedure consisted of an initial denaturation step of 4 min at
96 °C followed by 27 cycles of 30 s at 95 °C, 30 s at 58 °C,
and 1.5 min at 72 °C. From cycle 11, the extension time at
72 °C was increased by 5 s each cycle. The amplification was
completed with 7 min at 72 °C and 10 s at 26 °C. The ramp
speed was 2 s/°C. Amplification products were run on 6%
acrylamide gels (19:1; acrylamide:bisacrylamide) in 2X TAE
buffer for 30 min and stained with silver staining to visualize
the bands. The molecular weight marker was HpaII-digested
plasmid, pUC19 (catalog number DMWP-1; Geneworks,
Adelaide, South Australia, Australia).
RESULTS
Initial attempts using the same primers as a previous study
[4] failed to amplify exon 4 of PITX3 in the DNA of members
of this family. This could be due to the high GC content (67%
GC) of the amplicon (Figure 3). The PCR protocol finally
adopted (see Methods) allowed visualization of the DNA
fragment following electrophoresis and silver staining. All
tested individuals with cataract or manifestations of ASMD
had amplicons of two sizes, 214 bp and 231 bp (Figure 4A),
while all those with normal eye development had only one
band, the smaller 214 bp fragment. There was also a larger
heteroduplex band in the heterozygotes, which was missing
from those without the duplication. DNA from one individual
(III-5) was sequenced and showed the presence of the
insertion on one copy of chromosome 10 (Figure 4B) similar
to the result seen previously [4,5,7].
Prenatal diagnosis was performed for IV-9 and IV-10, the
children of III-5, following chorionic villus biopsy. The result
for IV-9 showed heterozygosity for the same insertion allele
(Figure 5). The parents elected to continue the pregnancy, and
a healthy child with no corneal abnormalities was born. A
small cataract was observed at six months of age. The result
for IV-10 showed only the normal band (Figure 5), and the
baby was healthy with no corneal or lens abnormalities.
Figure 3. Sequence of exon 4 of PITX3. Primers are shown in bold.
The 11 bp repeated sequence is underlined, and the 17 bp duplication
within this block is enclosed in square brackets. The sequence
terminates at the TGA stop codon.
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DISCUSSION
A study of Australian cataract patients [7] revealed only one
family with the 17 bp insertion mutation in 101 families. We
have now identified a second family with more extensive
disease [3] in which the recurrent 17 bp duplication of PITX3
(c.657ins17bp) segregates with ASMD. Family members in
our study have no knowledge of any relatives living in the
same area of the country as the other family, suggesting that
the mutations are independent. This is consistent with the
different manifestations of anterior segment abnormalities in
the two families and the probable de novo origin of the
mutation in individual I-5 [3].
The protein encoded by this gene controls the early stages
of normal development of the eye of mammals and other
vertebrates [10,11]. It functions as a transcription factor,
Figure 4. Analysis of exon 4 of PITX3.  A: The gel of amplification
products is shown. The 231 bp band containing the insertion is clearly
separated from the 214 bp band. A heteroduplex band can also be
seen in heterozygous individuals. –ve stands for the unaffected,
control individual. M stands for the molecular weight marker, a HpaII
digest of the plasmid pUC19. The bands either side of the
amplification products are 190 and 242 bp. The heteroduplex runs
with the 331 bp band. B: The sequence of exon 4, containing the
insertion, for individual III-5 is shown.
regulating the expression of genes that act downstream of
PAX6 in eye development. Families with the PITX3 insertion
have no abnormalities in other organ systems, and it is likely
that the PITX3 protein is exclusively involved in eye
development. The variable phenotypic impact of the insertion
(from cataract in most families to severe ASMD in some
individuals) may be due to modifier loci, which could include
any of the genes previously shown to harbor mutations in
ASMD (see Table 1), or to environmental effects influencing
eye development during gestation. All of the affected
individuals in our family gave an identical fragment size for
the insertion, ruling out the possibility that the more severe
phenotype is associated with further amplification of the
repeated sequence within the insertion.
In this family, the initial insertion may have occurred in
the oldest case examined (individual I-5). There is no evidence
that either of her parents was affected, and her two sisters and
aunt were shown in this study not to have the insertion.
Individual I-5 had cataracts but no other anterior segment
abnormalities when examined at the age of 86 years. One of
her daughters, II-7, is the most severely affected family
member while three of her granddaughters and three of her
great granddaughters have some signs of ASMD [3]. In most
previously reported families, the duplication results in
posterior polar cataract without other anterior segment
abnormalities. While all affected individuals in our family
manifest cataract, half have additional signs of more extensive
disruption of eye development.
There is no male-to-male transmission of eye disease in
this family. Consistent with this, individual III-5 has recently
had an affected daughter (IV-9) and an unaffected son
Figure 5. Prenatal diagnosis of the inherited duplication. Gels of
amplification products are shown. Lanes 1 and 6 are a negative
control. Lanes 2 and 5 are the positive control, III-5. Lanes 3 and 4
show two dilutions of the CVS material for IV-9. Lanes 7 and 8 show
two dilutions of the CVS material for IV-10. M is the molecular
weight marker, a HpaII digest of pUC19. IV-9 has the insertion band
and IV-10 has only the normal band.
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(IV-10). The identification of the insertion in PITX3 rules out
X-linked inheritance. As noted in the previous paper [3], there
are very few at risk males and the majority of affected
individuals are female (14 out of 16). The high number of
female offspring in this family may also reflect a sex limited
effect of PITX3, which results in disproportionate loss of
affected male pregnancies. However, the two affected males,
III-5 and IV-7, have mild manifestations (cataracts only),
which suggests there is no increased severity in males carrying
the insertion.
Genetic counseling for this family is difficult because an
individual with relatively minor effects (for example I-5) can
have a severely affected child (II-7). However, in most family
members, the condition is not debilitating and they achieve
good visual acuity after cataract removal and intraocular lens
insertion. For those individuals with corneal clouding, simple
measures can be implemented such as the colored contact lens
matching the unaffected eye now worn by IV-2, which
provides cosmetic improvement and allows her to avoid
stigmatization because of her different eyes.
Chorionic villus samples from the pregnancies of III-5
and III-15 were tested for the presence of the insertion. The
first fetus (IV-9) was shown to have the duplication. After
consideration of possible outcomes, the parents who felt they
had bonded strongly with the fetus elected to continue the
pregnancy and to deal with the visual problems as they arise.
The baby had no signs of ASMD at birth but has a small non-
progressive opacity in one lens. Like her father, she will
probably develop more extensive cataracts as she ages but is
likely to retain good vision with the aid of cataract surgery.
Testing of the second pregnancy showed an unaffected fetus.
The availability of this simple PCR-based test has allowed
analysis of these pregnancies, but until the causes of
phenotypic variability can be elucidated, the extent of the
abnormality in any individual carrying the insertion cannot be
predicted.
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